Revvity EBITDA Margin 2010-2025 | RVTY
Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for Revvity (RVTY) over the last 10 years. The current EBITDA margin for Revvity as of June 30, 2025 is .
| Revvity EBITDA Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM EBITDA | EBITDA Margin |
| 2025-06-30 | $2.80B | $0.80B | 28.52% |
| 2025-03-31 | $2.77B | $0.80B | 28.81% |
| 2024-12-31 | $2.76B | $0.78B | 28.35% |
| 2024-09-30 | $2.72B | $0.74B | 27.19% |
| 2024-06-30 | $2.71B | $0.71B | 26.28% |
| 2024-03-31 | $2.73B | $0.71B | 25.90% |
| 2023-12-31 | $2.75B | $0.74B | 26.86% |
| 2023-09-30 | $2.80B | $0.80B | 28.54% |
| 2023-06-30 | $2.84B | $0.85B | 29.89% |
| 2023-03-31 | $3.02B | $1.02B | 33.70% |
| 2022-12-31 | $3.31B | $1.22B | 36.90% |
| 2022-09-30 | $3.00B | $1.38B | 45.92% |
| 2022-06-30 | $3.15B | $1.41B | 44.67% |
| 2022-03-31 | $3.48B | $1.46B | 41.87% |
| 2021-12-31 | $3.83B | $1.61B | 42.07% |
| 2021-09-30 | $3.63B | $1.63B | 44.88% |
| 2021-06-30 | $3.74B | $1.68B | 45.09% |
| 2021-03-31 | $3.32B | $1.51B | 45.47% |
| 2020-12-31 | $2.66B | $1.07B | 40.33% |
| 2020-09-30 | $3.23B | $0.86B | 26.60% |
| 2020-06-30 | $2.98B | $0.69B | 23.15% |
| 2020-03-31 | $2.89B | $0.60B | 20.92% |
| 2019-12-31 | $2.88B | $0.60B | 20.87% |
| 2019-09-30 | $2.84B | $0.56B | 19.82% |
| 2019-06-30 | $2.80B | $0.55B | 19.52% |
| 2019-03-31 | $2.78B | $0.54B | 19.34% |
| 2018-12-31 | $2.78B | $0.53B | 18.98% |
| 2018-09-30 | $2.66B | $0.49B | 18.33% |
| 2018-06-30 | $2.54B | $0.47B | 18.36% |
| 2018-03-31 | $2.39B | $0.43B | 17.89% |
| 2017-12-31 | $2.26B | $0.41B | 18.17% |
| 2017-09-30 | $2.18B | $0.40B | 18.42% |
| 2017-06-30 | $2.14B | $0.40B | 18.58% |
| 2017-03-31 | $2.13B | $0.39B | 18.21% |
| 2016-12-31 | $2.12B | $0.40B | 18.77% |
| 2016-09-30 | $2.00B | $0.35B | 17.56% |
| 2016-06-30 | $2.05B | $0.35B | 17.29% |
| 2016-03-31 | $2.08B | $0.36B | 17.34% |
| 2015-12-31 | $2.11B | $0.37B | 17.34% |
| 2015-09-30 | $2.10B | $0.30B | 14.51% |
| 2015-06-30 | $2.07B | $0.29B | 13.89% |
| 2015-03-31 | $2.07B | $0.29B | 13.99% |
| 2014-12-31 | $2.07B | $0.28B | 13.48% |
| 2014-09-30 | $2.22B | $0.40B | 17.90% |
| 2014-06-30 | $2.20B | $0.40B | 18.24% |
| 2014-03-31 | $2.18B | $0.38B | 17.18% |
| 2013-12-31 | $2.16B | $0.36B | 16.74% |
| 2013-09-30 | $2.13B | $0.24B | 11.12% |
| 2013-06-30 | $2.12B | $0.22B | 10.38% |
| 2013-03-31 | $2.10B | $0.23B | 10.95% |
| 2012-12-31 | $2.11B | $0.24B | 11.25% |
| 2012-09-30 | $2.08B | $0.25B | 11.82% |
| 2012-06-30 | $2.03B | $0.24B | 11.65% |
| 2012-03-31 | $1.98B | $0.22B | 11.10% |
| 2011-12-31 | $1.92B | $0.21B | 11.05% |
| 2011-09-30 | $1.85B | $0.27B | 14.84% |
| 2011-06-30 | $1.81B | $0.27B | 15.12% |
| 2011-03-31 | $1.76B | $0.26B | 15.04% |
| 2010-12-31 | $1.70B | $0.25B | 14.63% |
| 2010-09-30 | $1.54B | $0.23B | 14.85% |
| 2010-06-30 | $1.49B | $0.20B | 13.33% |
| 2010-03-31 | $1.51B | $0.20B | 13.45% |
| 2009-12-31 | $1.55B | $0.20B | 12.90% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $10.695B | $2.755B |
| Revvity Inc. provides products, services and solutions to the diagnostics, life sciences and applied services markets worldwide. Its operating segment includes Discovery & Analytical Solutions and Diagnostics. Discovery & Analytical Solutions segment provides instruments, reagents, informatics, software, subscriptions, detection and imaging technologies. Discovery & Analytical Solutions segment provides instruments, reagents, informatics, software, subscriptions, detection and imaging technologies. Revvity Inc., formerly known as PerkinElmer Inc., is based in Waltham, Massachusetts. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $148.745B | 27.59 |
| CVS Health (CVS) | United States | $90.318B | 11.23 |
| Elevance Health (ELV) | United States | $70.706B | 9.51 |
| Cencora (COR) | United States | $55.895B | 18.61 |
| DiDi Global (DIDIY) | China | $26.780B | 28.45 |
| Labcorp Holdings (LH) | United States | $22.945B | 18.24 |
| Natera (NTRA) | United States | $22.299B | 0.00 |
| BioMerieux (BMXMF) | France | $17.423B | 0.00 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $14.987B | 0.00 |
| ICON (ICLR) | Ireland | $13.870B | 13.35 |
| Medpace Holdings (MEDP) | United States | $13.114B | 34.71 |
| CochLear (CHEOY) | Australia | $12.814B | 0.00 |
| Solventum (SOLV) | United States | $12.614B | 13.01 |
| Viatris (VTRS) | United States | $12.300B | 4.38 |
| Caris Life Sciences,�Inc (CAI) | United States | $10.822B | 0.00 |
| Avantor (AVTR) | United States | $9.006B | 13.21 |
| Charles River Laboratories (CRL) | United States | $8.077B | 15.32 |
| Sonic Healthcare (SKHHY) | Australia | $7.700B | 0.00 |
| HealthEquity (HQY) | United States | $7.560B | 33.11 |
| Bausch + Lomb (BLCO) | Canada | $5.143B | 34.60 |
| Sotera Health (SHC) | United States | $4.656B | 26.02 |
| BrightSpring Health Services (BTSG) | United States | $4.266B | 32.54 |
| Amplifon S.p.A (AMFPF) | Italy | $3.937B | 21.83 |
| GeneDx Holdings (WGS) | United States | $3.501B | 80.18 |
| KindlyMD (NAKA) | United States | $3.449B | 0.00 |
| Alignment Healthcare (ALHC) | United States | $3.085B | 0.00 |
| Concentras Parent (CON) | United States | $3.002B | 19.04 |
| Surgery Partners (SGRY) | United States | $2.954B | 37.16 |
| Organon (OGN) | United States | $2.355B | 2.57 |
| Premier (PINC) | United States | $2.116B | 19.62 |
| Progyny (PGNY) | United States | $1.990B | 42.07 |
| Ardent Health (ARDT) | United States | $1.816B | 7.01 |
| PACS (PACS) | United States | $1.797B | 0.00 |
| Pediatrix Medical (MD) | United States | $1.486B | 9.92 |
| GoodRx Holdings (GDRX) | United States | $1.477B | 25.00 |
| Teladoc Health (TDOC) | United States | $1.355B | 0.00 |
| Omada Health (OMDA) | $1.209B | 0.00 | |
| Establishment Labs Holdings (ESTA) | $1.178B | 0.00 | |
| Ryman Healthcare (RYHTY) | New Zealand | $0.962B | 0.00 |
| Embecta (EMBC) | United States | $0.834B | 4.88 |
| AMN Healthcare Services Inc (AMN) | United States | $0.793B | 9.81 |
| CareDx (CDNA) | United States | $0.679B | 12.50 |
| Performant Healthcare (PHLT) | United States | $0.600B | 0.00 |
| Agilon Health (AGL) | United States | $0.572B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $0.519B | 89.00 |
| Nutex Health (NUTX) | United States | $0.497B | 7.53 |
| InnovAge Holding (INNV) | United States | $0.496B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.491B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.460B | 6.91 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.439B | 0.00 |
| SBC Medicals (SBC) | United States | $0.429B | 9.39 |
| Enhabit (EHAB) | United States | $0.409B | 26.90 |
| So-Young (SY) | China | $0.409B | 0.00 |
| Oncology Institute (TOI) | United States | $0.324B | 0.00 |
| LifeMD (LFMD) | United States | $0.294B | 0.00 |
| Beauty Health (SKIN) | United States | $0.266B | 0.00 |
| Shoulder Innovations (SI) | United States | $0.229B | 0.00 |
| DocGo (DCGO) | United States | $0.160B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.146B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.099B | 0.00 |
| Biodesix (BDSX) | United States | $0.072B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.059B | 0.00 |
| NeueHealth (NEUE) | United States | $0.059B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.039B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.037B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.025B | 0.00 |
| OSR Holdings (OSRH) | United States | $0.022B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.013B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.012B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.010B | 0.00 | |
| ModivCare (MODV) | United States | $0.010B | 0.00 |
| XWELL (XWEL) | United States | $0.006B | 0.00 |
| INVO Fertility (IVF) | United States | $0.005B | 0.00 |
| ISpecimen (ISPC) | United States | $0.005B | 0.00 |
| Aclarion (ACON) | United States | $0.004B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.004B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.002B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |